Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma.

ABSTRACT: Diffuse intrinsic pontine glioma (DIPG) is a primary glial glioma that occurs in all age groups but predominates in children and is the main cause of solid tumor-related childhood mortality. Due to its rapid progression, the inability to operate and insensitivity to most chemotherapies, there is a lack of effective treatment methods in clinical practice for DIPG patients. The prognosis of DIPG patients is extremely poor, with a median survival time of no more than 12 months. In recent years, there have been continuous breakthroughs for immunotherapies in various hematological tumors and malignant solid tumors with extremely poor prognoses, which provides new insights into tumors without effective treatment strategies. Meanwhile, with the gradual development of stereotactic biopsy technique

SUBMITTER: Chen Y 

PROVIDER: S-EPMC9913210 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature